Literature DB >> 12408843

Target-derived GFRalpha1 as an attractive guidance signal for developing sensory and sympathetic axons via activation of Cdk5.

Fernanda Ledda1, Gustavo Paratcha, Carlos F Ibáñez.   

Abstract

Immobilized and diffusible molecular cues regulate axon guidance during development. GFRalpha1, a GPI-anchored receptor for GDNF, is expressed as both membrane bound and secreted forms by accessory nerve cells and peripheral targets of developing sensory and sympathetic neurons during the period of target innervation. A relative deficit of GFRalpha1 in developing axons allows exogenous GFRalpha1 to capture GDNF and present it for recognition by axonal c-Ret receptors. Exogenous GFRalpha1 potentiates neurite outgrowth and acts as a long-range directional cue by creating positional information for c-Ret-expressing axons in the presence of a uniform concentration of GDNF. Soluble GFRalpha1 prolongs GDNF-mediated activation of cyclin-dependent kinase 5 (Cdk5), an event required for GFRalpha1-induced neurite outgrowth and axon guidance. Together with GDNF, target-derived GFRalpha1 can function in a non-cell-autonomous fashion as a chemoattractant cue with outgrowth promoting activity for peripheral neurons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408843     DOI: 10.1016/s0896-6273(02)01002-4

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  30 in total

Review 1.  Ligand-induced cell adhesion as a new mechanism to promote synapse formation.

Authors:  Fernanda Ledda
Journal:  Cell Adh Migr       Date:  2007-07-05       Impact factor: 3.405

2.  Stage specific requirement of Gfrα1 in the ureteric epithelium during kidney development.

Authors:  T Keefe Davis; Masato Hoshi; Sanjay Jain
Journal:  Mech Dev       Date:  2013-03-28       Impact factor: 1.882

3.  Protein-tyrosine phosphatase SHP2 contributes to GDNF neurotrophic activity through direct binding to phospho-Tyr687 in the RET receptor tyrosine kinase.

Authors:  Maurice Perrinjaquet; Marçal Vilar; Carlos F Ibáñez
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

Review 4.  Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

Authors:  Tiago Martins Rodrigues; André Jerónimo-Santos; Tiago Fleming Outeiro; Ana Maria Sebastião; Maria José Diógenes
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

5.  GFRα1 released by nerves enhances cancer cell perineural invasion through GDNF-RET signaling.

Authors:  Shuangba He; Chun-Hao Chen; Natalya Chernichenko; Shizhi He; Richard L Bakst; Fernando Barajas; Sylvie Deborde; Peter J Allen; Efsevia Vakiani; Zhenkun Yu; Richard J Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

6.  Long distance directional growth of dopaminergic axons along pathways of netrin-1 and GDNF.

Authors:  C Zhang; Y Jin; K S Ziemba; A M Fletcher; B Ghosh; E Truit; D M Yurek; G M Smith
Journal:  Exp Neurol       Date:  2013-10-04       Impact factor: 5.330

7.  Tiam1 as a signaling mediator of nerve growth factor-dependent neurite outgrowth.

Authors:  Shahrzad Shirazi Fard; Julianna Kele; Marçal Vilar; Gustavo Paratcha; Fernanda Ledda
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

8.  Target-dependent inhibition of sympathetic neuron growth via modulation of a BMP signaling pathway.

Authors:  Jung-Il Moon; Susan J Birren
Journal:  Dev Biol       Date:  2008-01-08       Impact factor: 3.582

Review 9.  The specification and wiring of mammalian cutaneous low-threshold mechanoreceptors.

Authors:  William Olson; Peter Dong; Michael Fleming; Wenqin Luo
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-03-17       Impact factor: 5.814

10.  GDNF hyperalgesia is mediated by PLCgamma, MAPK/ERK, PI3K, CDK5 and Src family kinase signaling and dependent on the IB4-binding protein versican.

Authors:  Oliver Bogen; Elizabeth K Joseph; Xiaojie Chen; Jon D Levine
Journal:  Eur J Neurosci       Date:  2008-06-28       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.